Quote:
Originally Posted by Av8rgirl
Since I am in one of those small company clinical trials, I was a little discouraged. The comment about not having the funding to bring these vaccines to market once they go through the trials is disheartening. Not enough so that I will not continue, but I certainly hope that once the vaccine has gone through all these clinical trials and proves to be helpful to us, I sure hope that the company is able to take it to market!
|
You have pretty much hit the nail on the head when it comes to developing drugs for MS. As another poster wrote, often we see the small company finding some success and then having to sell part of their drug's "rights" to a much larger company in order to develop it. Just look at Elan going to bed with Biogen in order to develop Tysabri.
While it is very true that the cost of a drug's development is huge, it makes you wonder why medications such as Avonex, Betaseron and Copaxone cost up to $ 18000.00 a year for each patient when they have been around for 15 years or more!! There is a decent profit and then there is greed. Then again, that's what our society is all about!
Harry